Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px
Organisation › Details

ViiV Healthcare

ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in treatment and care for people living with HIV. Shionogi joined in October 2012. The company’s aim is to take a deeper and broader interest in HIV/AIDS than any company has done before and take a new approach to deliver effective and new HIV medicines, as well as support communities affected by HIV. *

 

Period Start 2009-11-01 established jv
  Group GlaxoSmithKline (GSK) (Group)
Product Industry AIDS drug_o
Person Person Waterhouse, Deborah (ViiV Healthcare 201907 CEO)
     
Region Region Brentford, Greater London
  Country United Kingdom (GB)
  Street 980 Great West Road
  City TW8 9GS Brentford, Middlesex
  Tel +44-20-8380-6200
    Address record changed: 2013-11-04
     
Basic data Employees n. a.
     
    * Document for �About Section�: GlaxoSmithKline plc. (8/16/16). "Press Release: ViiV Healthcare Launches Phase III Programme Evaluating a Two-drug Regimen Combining Dolutegravir and Lamivudine for HIV-1 Treatment".
     
   
Record changed: 2019-07-04

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for GlaxoSmithKline (GSK) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSBNL] Life-Sciences-Benelux.com – The Business Web Portal 600x86px




» top